针对乙型肝炎病毒相关肝细胞癌患者的免疫疗法的进展
Wei-Hua Cao1, Ya-Qin Zhang1, Xin-Xin Li1
1Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
World journal of hepatology
|October 30, 2024
概括
在中国,乙型肝炎病毒 (HBV) 感染导致肝细胞癌 (HCC). 免疫疗法,包括干扰素和检查点抑制剂 (PD-1/L1,CTLA-4),为与HBV相关的HCC提供了新的治疗途径,特别是在中国患者中.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 免疫学和癌症生物学
背景情况:
- 乙型肝炎病毒 (HBV) 感染是肝细胞癌 (HCC) 的主要驱动因素,特别是在中国,它影响了超过92%的肝癌患者.
- 肝脏对慢性抗原的免疫耐受性在HBV-HCC中创造了一个独特的瘤微环境 (TME),使瘤细胞能够通过PD-1/L1和CTLA-4等途径逃避免疫监测.
- 干扰素和新兴免疫疗法正在改变HCC治疗,提供超越传统疗法的新希望.
研究的目的:
- 审查与HBV相关的HCC免疫疗法的当前进展.
- 探索各种免疫治疗策略的疗效,包括干扰素,PD-1/L1抑制剂,CTLA-4抑制剂和采用细胞转移.
- 讨论组合免疫疗法以及在中国患者的背景下,当前方法的挑战和缺陷.
主要方法:
- 对与HBV相关的HCC的免疫疗法策略的系统审查.
- 对专注于免疫检查点抑制剂 (PD-1/L1,CTLA-4) 和干扰素的临床研究的分析.
- 评估采用细胞转移和组合免疫疗法方法.
主要成果:
- 免疫疗法,特别是PD-1/L1抑制剂,代表了HCC治疗的重大进展.
- 干扰素在调节HBV-HCC TME方面显示出潜力.
- 来自全球研究的临床数据可能不能完全代表中国的HCC患者,这凸显了需要进行具体研究的需要.
结论:
- 免疫疗法,特别是针对PD-1/L1和CTLA-4通路,是HBV相关的HCC的一个有希望的前沿.
- 进一步的研究对于确定HBV-HCC的中国患者的最佳免疫疗法策略和组合至关重要,考虑到他们独特的疾病特征.
- 解决当前免疫疗法的缺陷对于改善患者的治疗结果至关重要.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
702
相关概念视频
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
01:30Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K